Merger of drugmakers Valeant, Actavis on hold: source
(Reuters) - Talks are on hold to merge drugmakers Valeant Pharmaceuticals International Inc and Actavis Inc in a deal that would have created a healthcare giant, a person familiar with the situation told Reuters on Saturday.
A Valeant spokeswoman and an Actavis spokesman could not be immediately reached for comment outside of business hours.
(Reporting by Soyoung Kim in New York; writing by Rod Nickel in Winnipeg, Manitoba)
© Thomson Reuters 2017 All rights reserved.